I dont disagree with your assessment. We have yuge potential ahead of us. The market has to catch up but its obvious the OTC doesn not help with traditional valuations especially with r&d companies. My last analysis showed $980M market cap within a few years after we commercialize or about $4 ps at the time. But, thats mechanical. I would adjust that figure up because of investor excitement driving up demand. How's that for a non-answer?
News 
Market Data 
Discover 
